Detalles de la búsqueda
1.
Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary.
Mol Cancer
; 12: 57, 2013 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-23758919
2.
A second-generation microRNA-based assay for diagnosing tumor tissue origin.
Oncologist
; 17(6): 801-12, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22618571
3.
Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.
J Clin Pathol
; 70(6): 500-507, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27798083
4.
Clinicians' Real World Perceptions of Pre-Nephrectomy Diagnostic Biopsy Performance as a Driver of Reduction in Unnecessary Surgeries in Renal Tumors.
J Kidney Cancer VHL
; 2(1): 1-14, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-28326254
5.
Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors.
Clin Exp Metastasis
; 30(4): 431-9, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23124598
6.
Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.
Mol Oncol
; 7(3): 732-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23587442
7.
Classification of the four main types of lung cancer using a microRNA-based diagnostic assay.
J Mol Diagn
; 14(5): 510-7, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22749746
Resultados
1 -
7
de 7
1
Próxima >
>>